Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Positron-Emission Tomography"" wg kryterium: Temat


Tytuł :
Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
Autorzy :
El-Galaly TC; Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Villa D; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, British Columbia, Canada.
Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.
Gormsen LC; Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2022 Apr; Vol. 197 (2), pp. 139-155. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphoma, Large B-Cell, Diffuse*/pathology
Positron Emission Tomography Computed Tomography*/methods
Fluorodeoxyglucose F18 ; Humans ; Positron-Emission Tomography ; Prognosis ; Retrospective Studies ; Tumor Burden
Czasopismo naukowe
Tytuł :
[Screening and preliminary validation of biomarkers in sputum-negative pulmonary tuberculosis based on positron emission tomography/computed tomography and transcriptomics].
Autorzy :
Wu LW; Department of Thoracic Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Wang L; Department of Thoracic Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Wen ZL; Department of Scientific Research, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Ma H; Department of Scientific Research, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Ou QF; Department of Tuberculosis, Wuxi No.5 People's Hospital, Wuxi 214007, China.
Wu C; Department of Tuberculosis, Changchun Infectious Disease Hospital, Changchun 130123, China.
Gao X; Department of PET-CT, Universal Medical Imaging, Shanghai 200233, China.
Shi L; Department of Thoracic Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Li HW; Department of Thoracic Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Xia F; Department of Lung Disease, the Navy's 905th Hospital, Shanghai 200050, China.
Song S; Department of Pathology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Zhu ZQ; Department of Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Liu HY; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
Chen XC; School of Basic Medicine, Medicine Collage, Shenzhen University, Shenzhen 518060, China.
Zhang SL; School of Basic Medicine, Medicine Collage, Shanghai Jiaotong University, Shanghai 200025, China.
Huang JY; Department of Scientific Research, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Song YZ; Department of Thoracic Surgery, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201052, China.
Pokaż więcej
Źródło :
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases [Zhonghua Jie He He Hu Xi Za Zhi] 2022 Jun 12; Vol. 45 (6), pp. 567-572.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*/methods
Tuberculosis, Pulmonary*/diagnostic imaging
Adult ; Biomarkers ; China ; Female ; Fluorodeoxyglucose F18/metabolism ; Humans ; Male ; Positron-Emission Tomography/methods ; ROC Curve ; Radiopharmaceuticals ; Retrospective Studies ; Sputum ; Transcriptome
Czasopismo naukowe
Tytuł :
Relating F-FDG image signal-to-noise ratio to time-of-flight noise-equivalent count rate in total-body PET using the uEXPLORER scanner.
Autorzy :
Leung EK; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.; UIH America, Inc., Houston, TX, United States of America.
Abdelhafez YG; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.
Berg E; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Xie Z; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Zhang X; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Bayerlein R; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.
Spencer B; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Li E; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Omidvari N; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Selfridge A; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.
Cherry SR; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Qi J; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Badawi RD; Department of Radiology, UC Davis Health, Sacramento, CA, United States of America.; Department of Biomedical Engineering, University of California, Davis, Davis, CA, United States of America.
Pokaż więcej
Źródło :
Physics in medicine and biology [Phys Med Biol] 2022 Jun 10; Vol. 67 (12). Date of Electronic Publication: 2022 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Positron-Emission Tomography*/methods
Humans ; Positron Emission Tomography Computed Tomography ; Signal-To-Noise Ratio ; Water
Czasopismo naukowe
Tytuł :
[Theranostics for Well and Moderately Differentiated GEP-NEN].
Autorzy :
Hartrampf P; Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Werner R; Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Buck A; Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Pokaż więcej
Transliterated Title :
Theranostics bei gut bis mäßig differenzierten GEP-NEN.
Źródło :
Zentralblatt fur Chirurgie [Zentralbl Chir] 2022 Jun; Vol. 147 (3), pp. 249-255. Date of Electronic Publication: 2022 Jun 15.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors*/diagnostic imaging
Neuroendocrine Tumors*/surgery
Positron Emission Tomography Computed Tomography*
Humans ; Positron-Emission Tomography ; Precision Medicine ; Radionuclide Imaging ; Radiopharmaceuticals ; Receptors, Somatostatin
Czasopismo naukowe
Tytuł :
Optimal and novel imaging of the adrenal glands.
Autorzy :
Navin PJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Moynagh MR
Pokaż więcej
Źródło :
Current opinion in endocrinology, diabetes, and obesity [Curr Opin Endocrinol Diabetes Obes] 2022 Jun 01; Vol. 29 (3), pp. 253-262.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Adrenal Gland Neoplasms*/diagnostic imaging
Positron-Emission Tomography*/methods
Adrenal Glands/diagnostic imaging ; Artificial Intelligence ; Humans ; Positron Emission Tomography Computed Tomography
Czasopismo naukowe
Tytuł :
PSMA PET: Enabling More Dose to Less Volume?
Autorzy :
Weg ES; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.
Zeng J; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Jun 01; Vol. 113 (2), pp. 255.
Typ publikacji :
Letter
MeSH Terms :
Gallium Radioisotopes*
Positron-Emission Tomography*
Gallium Isotopes ; Humans ; Positron Emission Tomography Computed Tomography
Opinia redakcyjna
Tytuł :
Pre-treatment F-RGD Uptake may Predict Adverse Events during Apatinib Antiangiogenic Therapy.
Autorzy :
Li L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zheng J; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Liu Z; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Huang Y; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Xiao J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Wang S; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yu Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhang Q; Department of Oncology, Zibo Forth People's Hospital, Zibo, Shandong, China.
Hu X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhao W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Hou W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Spring Kong FM; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Yu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Yuan S; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China. Electronic address: .
Pokaż więcej
Źródło :
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Jun; Vol. 34 (6), pp. e238-e245. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hypertension*
Positron Emission Tomography Computed Tomography*
Angiogenesis Inhibitors/adverse effects ; Fatigue ; Fluorodeoxyglucose F18 ; Humans ; Nausea ; Oligopeptides ; Positron-Emission Tomography ; Pyridines ; Quality of Life ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł :
Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [ F]FMISO PET/CT.
Autorzy :
Welz S; Department of Radiation Oncology, University Hospital Tübingen, University of Tübingen, Germany.
Paulsen F; Department of Radiation Oncology, University Hospital Tübingen, University of Tübingen, Germany.
Pfannenberg C; Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, University of Tübingen, Germany.
Reimold M; Department of Nuclear Medicine, University Hospital Tübingen, University of Tübingen, Germany.
Reischl G; Department of Preclinical Imaging and Radiopharmacy, University Hospital Tübingen, University of Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Germany.
Nikolaou K; Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, University of Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Germany.
La Fougère C; Department of Nuclear Medicine, University Hospital Tübingen, University of Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Germany.
Alber M; Section for Medical Physics, Department of Radiation Oncology, Heidelberg University, Germany.
Belka C; Department of Radiation Oncology, University of Munich, Germany; Department of Radiation Oncology, LMU Munich, Germany.
Zips D; Department of Radiation Oncology, University Hospital Tübingen, University of Tübingen, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; and German Cancer Consortium (DKTK), partner site Tübingen, Germany.
Thorwarth D; German Cancer Research Center (DKFZ), Heidelberg, Germany; and German Cancer Consortium (DKTK), partner site Tübingen, Germany; Section for Biomedical Physics, Department of Radiation Oncology, University Hospital Tübingen, University of Tübingen, Germany. Electronic address: .
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Jun; Vol. 171, pp. 30-36. Date of Electronic Publication: 2022 Apr 05.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Positron Emission Tomography Computed Tomography*
Humans ; Hypoxia ; Misonidazole/analogs & derivatives ; Positron-Emission Tomography/methods ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł :
Efficient and automatic synthesis of TSPO PET ligand [ F]-GE-180 and its application in rheumatoid arthritis model.
Autorzy :
Zhu XX; Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
He YL; School of Pharmacy, Bengbu Medical College, Bengbu, 233030, Anhui, China.
Xie JK; Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Wang KX; Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Wang SC; Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Xie Q; Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China; School of Pharmacy, Bengbu Medical College, Bengbu, 233030, Anhui, China. Electronic address: .
Pokaż więcej
Źródło :
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine [Appl Radiat Isot] 2022 Jun; Vol. 184, pp. 110213. Date of Electronic Publication: 2022 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Arthritis, Rheumatoid*/diagnostic imaging
Positron-Emission Tomography*/methods
Animals ; Carbazoles ; Carrier Proteins/metabolism ; Inflammation ; Ligands ; Positron Emission Tomography Computed Tomography ; Rats ; Receptors, GABA-A/metabolism
Czasopismo naukowe
Tytuł :
Data-driven gated CT: An automated respiratory gating method to enable data-driven gated PET/CT.
Autorzy :
Pan T; Department of Imaging Physics, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, USA.
Thomas MA; Department of Imaging Physics, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, USA.
Luo D; Department of Radiation Physics, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, USA.
Pokaż więcej
Źródło :
Medical physics [Med Phys] 2022 Jun; Vol. 49 (6), pp. 3597-3611. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :
Journal Article
MeSH Terms :
Four-Dimensional Computed Tomography*/methods
Positron Emission Tomography Computed Tomography*
Humans ; Motion ; Positron-Emission Tomography/methods ; Radionuclide Imaging
Czasopismo naukowe
Tytuł :
Lung Cancer Risk in Suspicious Lung Nodules With Negative Positron Emission Tomography.
Autorzy :
Akpoviroro O; Department of Surgery, Boston University School of Medicine, Boston Massachusetts.
Asokan S; Department of Surgery, Boston University School of Medicine, Boston Massachusetts.
Steiling K; Division of Pulmonary, Allergy, Sleep and Critical Care Medicine, Department of Medicine, Boston Medical Center, Boston, Massachusetts.
Rebello A; Department of Radiology, Boston University School of Medicine, Boston, Massachusetts.
Burks EJ; Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, Massachusetts.
Litle VR; Division of Thoracic Surgery, Department of Surgery, Boston University School of Medicine, Boston, Massachusetts.
Suzuki K; Division of Thoracic Surgery, Department of Surgery, Boston University School of Medicine, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2022 Jun; Vol. 113 (6), pp. 1821-1826. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/epidemiology
Positron-Emission Tomography*/methods
Fluorodeoxyglucose F18 ; Humans ; Lung/pathology ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł :
Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies.
Autorzy :
Presotto L; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Bettinardi V; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Bagnalasta M; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Scifo P; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Savi A; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vanoli EG; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Fallanca F; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Picchio M; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Perani D; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Gianolli L; Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
De Bernardi E; School of Medicine and Surgery, University of Milano-Bicocca, via Cadore 48, Monza, 20900, Italy. .; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4, University of Milan-Bicocca, Monza, Italy. .
Pokaż więcej
Źródło :
Journal of digital imaging [J Digit Imaging] 2022 Jun; Vol. 35 (3), pp. 432-445. Date of Electronic Publication: 2022 Jan 28.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Brain/anatomy & histology ; Brain/diagnostic imaging ; Humans ; Image Processing, Computer-Assisted/methods ; Magnetic Resonance Imaging/methods ; Multimodal Imaging/methods ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł :
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer.
Autorzy :
Rowe SP; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, United States.; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, United States.
Buck A; Nuclear Medicine, Würzburg University Medical Center Clinic for Nuclear Medicine, Würzburg, Germany.
Bundschuh RA; Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Lapa C; University of Augsburg, Augsburg, Germany.
Serfling SE; Nuclear Medicine, Würzburg University Medical Center Clinic for Nuclear Medicine, Würzburg, Germany.
Derlin T; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Higuchi T; Nuclear Medicine, Würzburg University Medical Center Clinic for Nuclear Medicine, Würzburg, Germany.; Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.
Gorin MA; Urology Associates and UPMC Western Maryland, Cumberland, United States.; Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, United States.
Pomper MG; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, United States.; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, United States.
Werner RA; Nuclear Medicine, Würzburg University Medical Center Clinic for Nuclear Medicine, Würzburg, Germany.
Pokaż więcej
Transliterated Title :
[18F]DCFPyL PET/CT zur Prostatakarzinom-Bildgebung.
Źródło :
Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2022 Jun; Vol. 61 (3), pp. 240-246. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Humans ; Male ; Positron-Emission Tomography ; Prospective Studies
Czasopismo naukowe
Tytuł :
Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors.
Autorzy :
Hapdey S; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France - .; QuantIF-LITIS EA4108, University of Rouen, Rouen, France - .
Dubray B; QuantIF-LITIS EA4108, University of Rouen, Rouen, France.; Department of Radiotherapy, Henri Becquerel Cancer Center, Rouen, France.
Chastan M; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.
Thureau S; QuantIF-LITIS EA4108, University of Rouen, Rouen, France.; Department of Radiotherapy, Henri Becquerel Cancer Center, Rouen, France.
Gouel P; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.
Edet-Sanson A; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.; QuantIF-LITIS EA4108, University of Rouen, Rouen, France.
Becker S; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.; QuantIF-LITIS EA4108, University of Rouen, Rouen, France.
Vera P; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.; QuantIF-LITIS EA4108, University of Rouen, Rouen, France.
Bouyeure-Petit AC; Department of Nuclear Medicine, Henri Becquerel Cancer Center, Rouen, France.
Pokaż więcej
Źródło :
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2022 Jun; Vol. 66 (2), pp. 171-178. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Positron Emission Tomography Computed Tomography*/methods
Fluorodeoxyglucose F18 ; Four-Dimensional Computed Tomography/methods ; Humans ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł :
Effect of PET-CT misalignment on the quantitative accuracy of cardiac O-water PET.
Autorzy :
Nordström J; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden. .; Centre for Research and Development, Uppsala/Gävleborg County, Gävle, Sweden. .; PET Centre, Uppsala University Hospital, 751 85, Uppsala, Sweden. .
Harms HJ; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.; Nuclear Medicine & Clinical Physiology, Aarhus University Hospital, Aarhus, Denmark.; MedTrace Pharma A/S, Lyngby, Denmark.
Kero T; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.; Medical Imaging Centre, Uppsala University Hospital, Uppsala, Sweden.
Ebrahimi M; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.; Nuclear Medicine & Clinical Physiology, Aarhus University Hospital, Aarhus, Denmark.
Sörensen J; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.; Nuclear Medicine & Clinical Physiology, Aarhus University Hospital, Aarhus, Denmark.; Medical Imaging Centre, Uppsala University Hospital, Uppsala, Sweden.; MedTrace Pharma A/S, Lyngby, Denmark.
Lubberink M; Department of Surgical Sciences/Nuclear Medicine & PET, Uppsala University, Uppsala, Sweden.; Medical Physics, Uppsala University Hospital, Uppsala, Sweden.; Nuclear Medicine & Clinical Physiology, Aarhus University Hospital, Aarhus, Denmark.; MedTrace Pharma A/S, Lyngby, Denmark.
Pokaż więcej
Źródło :
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2022 Jun; Vol. 29 (3), pp. 1119-1128. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Circulation*/physiology
Positron Emission Tomography Computed Tomography*
Heart ; Humans ; Oxygen Radioisotopes ; Positron-Emission Tomography ; Tomography, X-Ray Computed ; Water
Czasopismo naukowe
Tytuł :
Transporter Activity in Patients with Primary and Metastatic Brain Tumors.
Autorzy :
Wardak M; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Sonni I; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Fan AP; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Minamimoto R; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Jamali M; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Hatami N; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Zaharchuk G; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Fischbein N; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Nagpal S; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Li G; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Koglin N; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Berndt M; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Bullich S; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Stephens AW; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Dinkelborg LM; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Abel T; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Manning HC; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Rosenberg J; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Chin FT; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Gambhir SS; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Mittra ES; From the Department of Radiology, Molecular Imaging Program at Stanford (MIPS) (M.W., I.S., A.P.F., R.M., M.J., N.H., G.Z., N.F., J.R., F.T.C., S.S.G., E.S.M.), Department of Neurosurgery (N.F., S.N., G.L.), and Department of Neurology and Neurological Sciences (N.F., S.N., G.L.), Stanford University School of Medicine, Stanford, Calif; Department of Molecular and Medical Pharmacology, UCLA Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, Calif (I.S.); Department of Biomedical Engineering, Department of Neurology, University of California, Davis, Davis, Calif (A.P.F.); Stanford Bio-X (M.W., G.Z., G.L., F.T.C., S.S.G.) and Departments of Bioengineering (S.S.G.) and Materials Science & Engineering (S.S.G.), Stanford University, Stanford, Calif; Life Molecular Imaging GmbH, Berlin, Germany (N.K., M.B., S.B., A.W.S., L.M.D.); Department of Pathology, Microbiology and Immunology (T.A.) and Department of Radiology and Radiological Sciences, Institute of Imaging Science, Center for Molecular Probes (H.C.M.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Tex (H.C.M.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2022 Jun; Vol. 303 (3), pp. 620-631. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji :
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Positron Emission Tomography Computed Tomography*/methods
Fluorodeoxyglucose F18 ; Glutamic Acid ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography/methods ; Prospective Studies ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł :
Role of F-FDG PET/CT imaging in cardiac and pericardial masses.
Autorzy :
Yin H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Mao W; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Tan H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Zhu N; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Wan Q; Department of Echocardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shi J; Department of Echocardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Qiu L; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Xiu Y; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Luo R; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yu H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China.
Shi H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Rd, Shanghai, 200032, China. .
Pokaż więcej
Źródło :
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2022 Jun; Vol. 29 (3), pp. 1293-1303. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Journal Article
MeSH Terms :
Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*/methods
Heart ; Humans ; Positron-Emission Tomography ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Expect the Unexpected: Artifacts From Lodged 124I Capsule in Esophagus on PET/CT.
Autorzy :
Chua WM; From the Division of Radiological Sciences, Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital.
Tang CYL; From the Division of Radiological Sciences, Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital.
Tham WY
Yang SP
Tay YS; From the Division of Radiological Sciences, Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital.
Loke KSH
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2022 Jun 01; Vol. 47 (6), pp. 547-548. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Iodine Radioisotopes*
Positron Emission Tomography Computed Tomography*/methods
Artifacts ; Esophagus/diagnostic imaging ; Female ; Humans ; Middle Aged ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł :
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
Autorzy :
Gupta T; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India - .
Chatterjee A; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Rangarajan V; Department of Nuclear Medicine and Molecular Imaging, and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Purandare N; Department of Nuclear Medicine and Molecular Imaging, and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Arya S; Department of Radio-diagnosis, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Murthy V; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Budrukkar A; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Ghosh-Laskar S; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Agarwal JP; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Hospital (TMH), Tata Memorial Centre, Mumbai, India.
Pokaż więcej
Źródło :
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2022 Jun; Vol. 66 (2), pp. 162-170. Date of Electronic Publication: 2019 Sep 05.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/therapy
Positron Emission Tomography Computed Tomography*/methods
Diffusion Magnetic Resonance Imaging ; Fluorodeoxyglucose F18/metabolism ; Humans ; Hypoxia ; Positron-Emission Tomography ; Radiopharmaceuticals ; Squamous Cell Carcinoma of Head and Neck/diagnostic imaging ; Squamous Cell Carcinoma of Head and Neck/therapy ; Tumor Burden
Czasopismo naukowe
Tytuł :
Immuno-Imaging (PET/SPECT)-Quo Vadis?
Autorzy :
Kramer CS; Curanosticum Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, D-65191 Wiesbaden, Germany.
Dimitrakopoulou-Strauss A; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, D-69120 Heidelberg, Germany.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2022 May 23; Vol. 27 (10). Date of Electronic Publication: 2022 May 23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Neoplasms*/diagnostic imaging
Positron Emission Tomography Computed Tomography*/methods
Humans ; Immunotherapy ; Positron-Emission Tomography/methods ; Tomography, Emission-Computed, Single-Photon
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies